Shop Apotheke Europe N.V. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was EUR 876.52 million compared to EUR 772.3 million a year ago. Net loss was EUR 67.88 million compared to EUR 31.7 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.5 EUR | -9.13% | -11.48% | -16.79% |
26/04 | REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating | ZD |
26/04 | REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating | ZD |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.79% | 2.42B | |
-30.37% | 15.68B | |
-19.95% | 12.39B | |
-22.88% | 6.74B | |
-5.87% | 6.29B | |
+11.76% | 6.26B | |
+70.00% | 4.95B | |
-1.90% | 4.7B | |
-5.58% | 4.03B | |
-7.87% | 3.62B |
- Stock Market
- Equities
- RDC Stock
- News Redcare Pharmacy NV
- Shop Apotheke Europe N.V. Reports Earnings Results for the Nine Months Ended September 30, 2022